SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin

Cancer Cell

Volumn 30, Issue 4, 2016, Pages 519-532

  Ferone, Giustina ^a   Song, Ji Ying ^a   Sutherland, Kate D ^b,c   Bhaskaran, Rajith ^a,d   Monkhorst, Kim ^a   Lambooij, Jan Paul ^a   Proost, Natalie ^a   Gargiulo, Gaetano ^e   Berns, Anton ^a,d  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR SOX2; SOX2 PROTEIN, HUMAN; SOX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL; CELL FATE; CONTROLLED STUDY; GENE OVEREXPRESSION; LUNG ALVEOLUS CELL TYPE 2; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL LUNG CARCINOMA; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR MICROENVIRONMENT;

EID: 84991809206     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.09.001     Document Type: Article

References (58)

1. Adamson, I.Y., Bowden, D.H., The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab. Invest. 30 (1974), 35–42.
2. Bass, A.J., Watanabe, H., Mermel, C.H., Yu, S., Perner, S., Verhaak, R.G., Kim, S.Y., Wardwell, L., Tamayo, P., Gat-Viks, I., et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet. 41 (2009), 1238–1242.
3. Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511 (2014), 246–250.
4. Brcic, L., Sherer, C.K., Shuai, Y., Hornick, J.L., Chirieac, L.R., Dacic, S., Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2. Am. J. Clin. Pathol. 138 (2012), 712–718.
5. Cancer Genome Atlas Research Network, Comprehensive genomic characterization of squamous cell lung cancers. Nature 489 (2012), 519–525.
6. Cancer Genome Atlas Research Network, Comprehensive molecular profiling of lung adenocarcinoma. Nature 511 (2014), 543–550.
7. Chioda, M., Peranzoni, E., Desantis, G., Papalini, F., Falisi, E., Solito, S., Mandruzzato, S., Bronte, V., Myeloid cell diversification and complexity: an old concept with new turns in oncology. Cancer Metastasis Rev. 30 (2011), 27–43.
8. Condamine, T., Gabrilovich, D.I., Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32 (2011), 19–25.
9. Daniely, Y., Liao, G., Dixon, D., Linnoila, R.I., Lori, A., Randell, S.H., Oren, M., Jetten, A.M., Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. Am. J. Physiol. Cell Physiol. 287 (2004), C171–C181.
10. Evans, M.J., Cabral, L.J., Stephens, R.J., Freeman, G., Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp. Mol. Pathol. 22 (1975), 142–150.
11. Ferone, G., Thomason, H.A., Antonini, D., De Rosa, L., Hu, B., Gemei, M., Zhou, H., Ambrosio, R., Rice, D.P., Acampora, D., et al. Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome. EMBO Mol. Med. 4 (2012), 192–205.
12. Ferone, G., Mollo, M.R., Thomason, H.A., Antonini, D., Zhou, H., Ambrosio, R., De Rosa, L., Salvatore, D., Getsios, S., van Bokhoven, H., et al. p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome. Hum. Mol. Genet. 22 (2013), 531–543.
13. Filipazzi, P., Huber, V., Rivoltini, L., Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol. Immunother. 61 (2012), 255–263.
14. Funai, K., Yokose, T., Ishii, G., Araki, K., Yoshida, J., Nishimura, M., Nagai, K., Nishiwaki, Y., Ochiai, A., Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am. J. Surg. Pathol. 27 (2003), 978–984.
15. Giangreco, A., Groot, K.R., Janes, S.M., Lung cancer and lung stem cells: strange bedfellows?. Am. J. Respir. Crit. Care Med. 175 (2007), 547–553.
16. Hayashi, T., Sano, H., Egashira, R., Tabata, K., Tanaka, T., Nakayama, T., Kashima, Y., Hori, T., Nunomura, S., Fukuoka, J., Difference of morphology and immunophenotype between central and peripheral squamous cell carcinomas of the lung. Biomed. Res. Int., 2013, 2013, 157838.
17. Hong, K.U., Reynolds, S.D., Watkins, S., Fuchs, E., Stripp, B.R., In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004), L643–L649.
18. Hussenet, T., Dali, S., Exinger, J., Monga, B., Jost, B., Dembele, D., Martinet, N., Thibault, C., Huelsken, J., Brambilla, E., du Manoir, S., SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One, 5, 2010, e8960.
19. Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., Tuveson, D.A., Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15 (2001), 3243–3248.
20. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics. CA Cancer J. Clin. 61 (2011), 69–90.
21. Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., Berns, A., Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29 (2001), 418–425.
22. Kim, C.F., Jackson, E.L., Woolfenden, A.E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R.T., Jacks, T., Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005), 823–835.
23. Krimpenfort, P., Ijpenberg, A., Song, J.Y., van der Valk, M., Nawijn, M., Zevenhoven, J., Berns, A., p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448 (2007), 943–946.
24. Liu, S., Chen, Z., Zhu, F., Hu, Y., IkappaB kinase alpha and cancer. J. Interferon Cytokine Res. 32 (2012), 152–158.
25. Liu, K., Jiang, M., Lu, Y., Chen, H., Sun, J., Wu, S., Ku, W.Y., Nakagawa, H., Kita, Y., Natsugoe, S., et al. Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell 12 (2013), 304–315.
26. Lu, Y., Futtner, C., Rock, J.R., Xu, X., Whitworth, W., Hogan, B.L., Onaitis, M.W., Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One, 5, 2010, e11022.
27. Malkoski, S.P., Cleaver, T.G., Thompson, J.J., Sutton, W.P., Haeger, S.M., Rodriguez, K.J., Lu, S.L., Merrick, D., Wang, X.J., Role of PTEN in basal cell derived lung carcinogenesis. Mol. Carcinog 53 (2014), 841–846.
28. Marino, S., Krimpenfort, P., Leung, C., van der Korput, H.A., Trapman, J., Camenisch, I., Berns, A., Brandner, S., PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 129 (2002), 3513–3522.
29. Mukhopadhyay, A., Berrett, K.C., Kc, U., Clair, P.M., Pop, S.M., Carr, S.R., Witt, B.L., Oliver, T.G., Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer. Cell Rep. 8 (2014), 40–49.
30. Murdoch, C., Muthana, M., Coffelt, S.B., Lewis, C.E., The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8 (2008), 618–631.
31. Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., Luo, L., A global double-fluorescent Cre reporter mouse. Genesis 45 (2007), 593–605.
32. Ramirez, A., Page, A., Gandarillas, A., Zanet, J., Pibre, S., Vidal, M., Tusell, L., Genesca, A., Whitaker, D.A., Melton, D.W., Jorcano, J.L., A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 39 (2004), 52–57.
33. Rawlins, E.L., Okubo, T., Xue, Y., Brass, D.M., Auten, R.L., Hasegawa, H., Wang, F., Hogan, B.L., The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4 (2009), 525–534.
34. Rock, J.R., Onaitis, M.W., Rawlins, E.L., Lu, Y., Clark, C.P., Xue, Y., Randell, S.H., Hogan, B.L., Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl. Acad. Sci. USA 106 (2009), 12771–12775.
35. Sakurai, H., Asamura, H., Watanabe, S., Suzuki, K., Tsuchiya, R., Clinicopathologic features of peripheral squamous cell carcinoma of the lung. Ann. Thorac. Surg. 78 (2004), 222–227.
36. Senoo, M., Pinto, F., Crum, C.P., McKeon, F., p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129 (2007), 523–536.
37. Serresi, M., Gargiulo, G., Proost, N., Siteur, B., Cesaroni, M., Koppens, M., Xie, H., Sutherland, K.D., Hulsman, D., Citterio, E., et al. Polycomb repressive complex 2 is a barrier to KRAS-driven inflammation and epithelial-mesenchymal transition in non-small-cell lung cancer. Cancer Cell 29 (2016), 17–31.
38. Sholl, L.M., Long, K.B., Hornick, J.L., Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas. Appl. Immunohistochem. Mol. Morphol. 18 (2010), 55–61.
39. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J. Clin. 65 (2015), 5–29.
40. Sutherland, K.D., Berns, A., Cell of origin of lung cancer. Mol. Oncol. 4 (2010), 397–403.
41. Sutherland, K.D., Proost, N., Brouns, I., Adriaensen, D., Song, J.Y., Berns, A., Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell 19 (2011), 754–764.
42. Sutherland, K.D., Song, J.Y., Kwon, M.C., Proost, N., Zevenhoven, J., Berns, A., Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma. Proc. Natl. Acad. Sci. USA 111 (2014), 4952–4957.
43. Thomason, H.A., Zhou, H., Kouwenhoven, E.N., Dotto, G.P., Restivo, G., Nguyen, B.C., Little, H., Dixon, M.J., van Bokhoven, H., Dixon, J., Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J. Clin. Invest. 120 (2010), 1561–1569.
44. Tonon, G., Wong, K.K., Maulik, G., Brennan, C., Feng, B., Zhang, Y., Khatry, D.B., Protopopov, A., You, M.J., Aguirre, A.J., et al. High-resolution genomic profiles of human lung cancer. Proc. Natl. Acad. Sci. USA 102 (2005), 9625–9630.
45. Travis, W.D., Pathology of lung cancer. Clin. Chest Med. 23 (2002), 65–81 viii.
46. Tsuta, K., Tanabe, Y., Yoshida, A., Takahashi, F., Maeshima, A.M., Asamura, H., Tsuda, H., Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. J. Thorac. Oncol. 6 (2011), 1190–1199.
47. Visvader, J.E., Cells of origin in cancer. Nature 469 (2011), 314–322.
48. Walker, S., Updates in non-small cell lung cancer. Clin. J. Oncol. Nurs. 12 (2008), 587–596.
49. Weiss, J., Sos, M.L., Seidel, D., Peifer, M., Zander, T., Heuckmann, J.M., Ullrich, R.T., Menon, R., Maier, S., Soltermann, A., et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci. Transl Med., 2, 2010, 62ra93.
50. Wilkerson, M.D., Yin, X., Hoadley, K.A., Liu, Y., Hayward, M.C., Cabanski, C.R., Muldrew, K., Miller, C.R., Randell, S.H., Socinski, M.A., et al. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin. Cancer Res. 16 (2010), 4864–4875.
51. Wu, D., Pang, Y., Wilkerson, M.D., Wang, D., Hammerman, P.S., Liu, J.S., Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity. Br. J. Cancer 109 (2013), 1599–1608.
52. Xiao, Z., Jiang, Q., Willette-Brown, J., Xi, S., Zhu, F., Burkett, S., Back, T., Song, N.Y., Datla, M., Sun, Z., et al. The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas. Cancer Cell 23 (2013), 527–540.
53. Xu, C., Fillmore, C.M., Koyama, S., Wu, H., Zhao, Y., Chen, Z., Herter-Sprie, G.S., Akbay, E.A., Tchaicha, J.H., Altabef, A., et al. Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression. Cancer Cell 25 (2014), 590–604.
54. Youn, J.I., Gabrilovich, D.I., The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40 (2010), 2969–2975.
55. Youn, J.I., Nagaraj, S., Collazo, M., Gabrilovich, D.I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181 (2008), 5791–5802.
56. Youn, J.I., Collazo, M., Shalova, I.N., Biswas, S.K., Gabrilovich, D.I., Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91 (2012), 167–181.
57. Yousem, S.A., Peripheral squamous cell carcinoma of lung: patterns of growth with particular focus on airspace filling. Hum. Pathol. 40 (2009), 861–867.
58. Zou, W., Wolchok, J.D., Chen, L., PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl Med., 8, 2016, 328rv324.